Pub Date : 2025-10-15eCollection Date: 2025-01-01DOI: 10.1155/jotm/6675295
Chenchen Yang, Yu Hu, Juanjuan Fu
Objective: This study aimed to investigate the clinical features of patients with autoimmune liver disease (AILD) following coronavirus disease 2019 (COVID-19).
Methods: For the AILD group, 19 inpatients who were first diagnosed with AILD were enrolled from Wuxi Fifth People's Hospital between January 2021 and December 2021. The post-COVID-19 AILD group comprised seven patients recruited after December 2022 who were initially diagnosed with COVID-19 and later diagnosed with AILD. Routine blood indices, biochemical parameters, serum-related antibodies, and serum immunoglobulin levels were assessed in the two groups. Ultrasound-guided liver biopsy was performed to observe the pathological characteristics of the liver in the two groups. The expression of immune indices in the two groups was observed by immunohistochemistry.
Results: The age and calcium levels of the post-COVID-19 AILD patients were significantly lower than those of the AILD patients (p < 0.05). The IgM levels were significantly higher in the post-COVID-19 AILD group than in the AILD group (p < 0.05). No significant differences in the other routine blood and blood biochemical indices were present between the two groups. The antinuclear antibody (ANA) and SM antibody levels were compared, revealing a significantly higher percentage of ANA positivity among post-COVID-19 AILD patients than AILD patients (p < 0.05).
Conclusion: AILD following COVID-19 has typical AILD characteristics, including acute onset, but has other characteristics that allow it to be distinguished from other AILDs.
{"title":"A Preliminary Study on Clinical Characteristics of Patients With Autoimmune Liver Following Coronavirus Disease 2019.","authors":"Chenchen Yang, Yu Hu, Juanjuan Fu","doi":"10.1155/jotm/6675295","DOIUrl":"10.1155/jotm/6675295","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the clinical features of patients with autoimmune liver disease (AILD) following coronavirus disease 2019 (COVID-19).</p><p><strong>Methods: </strong>For the AILD group, 19 inpatients who were first diagnosed with AILD were enrolled from Wuxi Fifth People's Hospital between January 2021 and December 2021. The post-COVID-19 AILD group comprised seven patients recruited after December 2022 who were initially diagnosed with COVID-19 and later diagnosed with AILD. Routine blood indices, biochemical parameters, serum-related antibodies, and serum immunoglobulin levels were assessed in the two groups. Ultrasound-guided liver biopsy was performed to observe the pathological characteristics of the liver in the two groups. The expression of immune indices in the two groups was observed by immunohistochemistry.</p><p><strong>Results: </strong>The age and calcium levels of the post-COVID-19 AILD patients were significantly lower than those of the AILD patients (<i>p</i> < 0.05). The IgM levels were significantly higher in the post-COVID-19 AILD group than in the AILD group (<i>p</i> < 0.05). No significant differences in the other routine blood and blood biochemical indices were present between the two groups. The antinuclear antibody (ANA) and SM antibody levels were compared, revealing a significantly higher percentage of ANA positivity among post-COVID-19 AILD patients than AILD patients (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>AILD following COVID-19 has typical AILD characteristics, including acute onset, but has other characteristics that allow it to be distinguished from other AILDs.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"6675295"},"PeriodicalIF":2.5,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-12eCollection Date: 2025-01-01DOI: 10.1155/jotm/9989759
Faysal Mollah, Mst Muslima Khatun, Raihan Chowdhury, Md Shimul Bhuia, Jeba Anika Sultan, Sharmita Ghosh Situ, Md Sakib Al Hasan, Hossam Kamli, Muhammad Torequl Islam
Linarin, a flavonoid glycoside found in the Asteraceae, Lamiaceae, and Scrophulariaceae families, shows diverse therapeutic benefits in laboratory studies. This study aims to evaluate the pharmacological effects of linarin through clinical and preclinical experiments, investigating its mechanisms against different diseases. To achieve this, data collection and search operations were carried out (current as of April 09, 2024) in several reliable online databases, such as PubMed/Medline, Scopus, Springer Link, ScienceDirect, Wiley Online, Web of Science, and Google Scholar, as part of this research. Studies revealed that linarin provides benefits against inflammation and various diseases, including osteoporosis, osteoarthritis, liver injuries, diabetes, hypertension, and neurodegenerative conditions, such as Alzheimer's, ischemia-reperfusion, convulsions, and depression. Our results further reveal that linarin displays remarkable anticancer potentials through multiple molecular pathways, including apoptotic cell death, oxidative stress induction, cytotoxic effect, antiproliferative effect, genotoxic effect, and mitigation of cancer cell migration and invasion and migration against a range of malignancies, including lung, brain, prostate, and glioma cell cancers. Database reports and the current literature-based study suggest that linarin might be a prospective lead chemical for treating a range of illnesses and ailments. For linarin to be proven as a medicine, further clinical and preclinical trials are required.
Linarin是一种黄酮类苷,存在于菊科、Lamiaceae和苦参科中,在实验室研究中显示出多种治疗效果。本研究旨在通过临床和临床前实验,评价linarin的药理作用,探讨其对不同疾病的作用机制。为了实现这一目标,在几个可靠的在线数据库中进行了数据收集和搜索操作(截至2024年4月9日),如PubMed/Medline、Scopus、施普林格Link、ScienceDirect、Wiley online、Web of Science和谷歌Scholar,作为本研究的一部分。研究表明,linarin对炎症和各种疾病有好处,包括骨质疏松症、骨关节炎、肝损伤、糖尿病、高血压和神经退行性疾病,如阿尔茨海默氏症、缺血再灌注、抽搐和抑郁症。我们的研究结果进一步表明,linarin通过多种分子途径显示出显著的抗癌潜力,包括凋亡细胞死亡、氧化应激诱导、细胞毒性作用、抗增殖作用、基因毒性作用,以及减缓癌细胞迁移、侵袭和迁移,对抗一系列恶性肿瘤,包括肺癌、脑癌、前列腺癌和胶质瘤细胞癌。数据库报告和目前基于文献的研究表明,linarin可能是治疗一系列疾病和疾病的潜在铅化学品。为了证明linarin是一种药物,需要进一步的临床和临床前试验。
{"title":"Therapeutic Promises of Bioactive Linarin, a Glycosylated Flavonoid: A Comprehensive Review With Mechanistic Insight.","authors":"Faysal Mollah, Mst Muslima Khatun, Raihan Chowdhury, Md Shimul Bhuia, Jeba Anika Sultan, Sharmita Ghosh Situ, Md Sakib Al Hasan, Hossam Kamli, Muhammad Torequl Islam","doi":"10.1155/jotm/9989759","DOIUrl":"10.1155/jotm/9989759","url":null,"abstract":"<p><p>Linarin, a flavonoid glycoside found in the Asteraceae, Lamiaceae, and Scrophulariaceae families, shows diverse therapeutic benefits in laboratory studies. This study aims to evaluate the pharmacological effects of linarin through clinical and preclinical experiments, investigating its mechanisms against different diseases. To achieve this, data collection and search operations were carried out (current as of April 09, 2024) in several reliable online databases, such as PubMed/Medline, Scopus, Springer Link, ScienceDirect, Wiley Online, Web of Science, and Google Scholar, as part of this research. Studies revealed that linarin provides benefits against inflammation and various diseases, including osteoporosis, osteoarthritis, liver injuries, diabetes, hypertension, and neurodegenerative conditions, such as Alzheimer's, ischemia-reperfusion, convulsions, and depression. Our results further reveal that linarin displays remarkable anticancer potentials through multiple molecular pathways, including apoptotic cell death, oxidative stress induction, cytotoxic effect, antiproliferative effect, genotoxic effect, and mitigation of cancer cell migration and invasion and migration against a range of malignancies, including lung, brain, prostate, and glioma cell cancers. Database reports and the current literature-based study suggest that linarin might be a prospective lead chemical for treating a range of illnesses and ailments. For linarin to be proven as a medicine, further clinical and preclinical trials are required.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9989759"},"PeriodicalIF":2.5,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145337341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-05eCollection Date: 2025-01-01DOI: 10.1155/jotm/2727632
Dawit Gebremichael
Bovine tuberculosis (bTB) has significant economic losses on the livestock productivity and poses serious public health risks worldwide. In Ethiopia, bTB is endemic and distributed across all parts of the country. Therefore, the systematic review aims to provide comprehensive investigations of the trends, risk factors, and zoonotic impacts of bTB in Ethiopia. Only English language publications from 2009 to 2022 were included. Databases searched included PubMed, PubMed Central, Medline, Scopus, Web of Science, Google Scholar, and ResearchGate. From a total of 129 articles retrieved, only 44 studies fulfilled the eligibility criteria. The overall pooled prevalence of bTB over 15 years was 11.04%. Female cattle had a significantly higher prevalence (19.85%) compared to male cattle (4.07%) (p=0.002). Emaciated animals were more affected than those in good body condition (p=0.04). Prevalence differed significantly among intensive (22.60%), semi-intensive (17.08%), and extensive (13.70%) production systems (p=0.01). The prevalence of bTB showed statistical significance (p=0.001) in three different breeds. Exotic breeds had the highest prevalence (28.46%), followed by crossed (12.61%) and local breeds (9.56%). Large herds showed a higher prevalence (42.69%) compared to medium (12.13%) and small herds (11.26%) (p=0.001). Poor management systems had a higher positivity rate (31.27%) compared to medium (15.23%) and good (9.89%) management systems (p=0.01). Studies with sample sizes less than 400 reported higher prevalence (20.70%) compared to those with 400-800 samples (11.70%) and more than 800 samples (5.83%) (p=0.001). Significant variations were observed among different diagnosis techniques (p=0.004). Only 40.82% and 35.51% of cattle owners had knowledge of bTB and awareness of its zoonotic impacts, respectively. Overall, the trends of bTB remain a significant impact in Ethiopia, affecting both livestock productivity and public health. Understanding these trends is essential for the development of evidence-based control strategies. The integration of epidemiological modeling with public health impact assessments can further strengthen policy formulation and guide resource prioritization more effectively. Therefore, effective control and prevention measures, along with continuous public education, are essential to mitigate economic losses and reduce the zoonotic impacts of bTB in the country. Using improved diagnostic techniques should be recommended to estimate the actual prevalence of the disease.
牛结核病(bTB)对畜牧业生产力造成重大经济损失,并在世界范围内构成严重的公共卫生风险。在埃塞俄比亚,结核是一种地方性疾病,分布在全国各地。因此,本系统综述旨在全面调查埃塞俄比亚bTB的趋势、危险因素和人畜共患影响。仅包括2009年至2022年的英文出版物。检索的数据库包括PubMed、PubMed Central、Medline、Scopus、Web of Science、b谷歌Scholar和ResearchGate。在总共检索到的129篇文章中,只有44篇研究符合资格标准。15年以上结核分枝杆菌总流行率为11.04%。母牛患病率为19.85%,显著高于公牛(4.07%)(p=0.002)。瘦弱的动物比体质良好的动物受影响更大(p=0.04)。在集约型(22.60%)、半集约型(17.08%)和粗放型(13.70%)生产系统中,患病率差异有统计学意义(p=0.01)。3个不同品种的bTB患病率均有统计学意义(p=0.001)。外来品种患病率最高(28.46%),其次是杂交品种(12.61%)和地方品种(9.56%)。大型畜群患病率为42.69%,高于中型畜群(12.13%)和小型畜群(11.26%)(p=0.001)。不良管理体系的阳性率(31.27%)高于中等管理体系(15.23%)和良好管理体系(9.89%)(p=0.01)。样本量小于400的研究报告的患病率(20.70%)高于400-800的研究(11.70%)和800以上的研究(5.83%)(p=0.001)。不同诊断技术间差异有统计学意义(p=0.004)。分别只有40.82%和35.51%的养牛人对疯牛病有了解,并了解其人畜共患的影响。总体而言,结核分枝杆菌的趋势仍然对埃塞俄比亚产生重大影响,影响到牲畜生产力和公共卫生。了解这些趋势对于制定循证控制战略至关重要。将流行病学建模与公共卫生影响评估相结合,可以进一步加强政策制定,更有效地指导资源优先排序。因此,有效的控制和预防措施,以及持续的公众教育,对于减轻经济损失和减少该国细菌性结核的人畜共患影响至关重要。应建议使用改进的诊断技术来估计该病的实际流行情况。
{"title":"Epidemiological Trend Analysis of Bovine Tuberculosis and Its Public Health Impact in Ethiopia.","authors":"Dawit Gebremichael","doi":"10.1155/jotm/2727632","DOIUrl":"10.1155/jotm/2727632","url":null,"abstract":"<p><p>Bovine tuberculosis (bTB) has significant economic losses on the livestock productivity and poses serious public health risks worldwide. In Ethiopia, bTB is endemic and distributed across all parts of the country. Therefore, the systematic review aims to provide comprehensive investigations of the trends, risk factors, and zoonotic impacts of bTB in Ethiopia. Only English language publications from 2009 to 2022 were included. Databases searched included PubMed, PubMed Central, Medline, Scopus, Web of Science, Google Scholar, and ResearchGate. From a total of 129 articles retrieved, only 44 studies fulfilled the eligibility criteria. The overall pooled prevalence of bTB over 15 years was 11.04%. Female cattle had a significantly higher prevalence (19.85%) compared to male cattle (4.07%) (<i>p</i>=0.002). Emaciated animals were more affected than those in good body condition (<i>p</i>=0.04). Prevalence differed significantly among intensive (22.60%), semi-intensive (17.08%), and extensive (13.70%) production systems (<i>p</i>=0.01). The prevalence of bTB showed statistical significance (<i>p</i>=0.001) in three different breeds. Exotic breeds had the highest prevalence (28.46%), followed by crossed (12.61%) and local breeds (9.56%). Large herds showed a higher prevalence (42.69%) compared to medium (12.13%) and small herds (11.26%) (<i>p</i>=0.001). Poor management systems had a higher positivity rate (31.27%) compared to medium (15.23%) and good (9.89%) management systems (<i>p</i>=0.01). Studies with sample sizes less than 400 reported higher prevalence (20.70%) compared to those with 400-800 samples (11.70%) and more than 800 samples (5.83%) (<i>p</i>=0.001). Significant variations were observed among different diagnosis techniques (<i>p</i>=0.004). Only 40.82% and 35.51% of cattle owners had knowledge of bTB and awareness of its zoonotic impacts, respectively. Overall, the trends of bTB remain a significant impact in Ethiopia, affecting both livestock productivity and public health. Understanding these trends is essential for the development of evidence-based control strategies. The integration of epidemiological modeling with public health impact assessments can further strengthen policy formulation and guide resource prioritization more effectively. Therefore, effective control and prevention measures, along with continuous public education, are essential to mitigate economic losses and reduce the zoonotic impacts of bTB in the country. Using improved diagnostic techniques should be recommended to estimate the actual prevalence of the disease.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"2727632"},"PeriodicalIF":2.5,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145292690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-04eCollection Date: 2025-01-01DOI: 10.1155/jotm/8376728
Ming-Kai Jhan, Ting-Jing Shen, Thi Thuy Nguyen, Chiou-Feng Lin
Dengue fever is highly prevalent in tropical and subtropical regions, where it is caused by dengue virus (DENV) and transmitted by arthropods. While DENV infection manifests with a spectrum of clinical symptoms, severe cases can lead to hemorrhagic fever and shock syndrome. Increasing evidence over the past decade has highlighted the neurological complications associated with DENV; however, the underlying mechanisms remain poorly understood. Despite this knowledge gap, various central nervous system (CNS)-targeted drugs have shown promise in mitigating DENV-induced neurological impairment. In this review, we provide an overview of the neurotropic features of DENV and summarize current evidence on the antiviral effects of selected nervous system-acting compounds. We also explore the potential mechanisms by which these agents may reduce DENV infection. Given the urgent need for effective dengue therapeutics, repurposing CNS-targeting drugs represents a promising strategy. Finally, we examine the potential and underlying mechanisms for employing neuropharmaceutical agents as one of the antiviral therapies for DENV infection.
{"title":"Repurposing Neurological Drugs Against Dengue Virus Infection.","authors":"Ming-Kai Jhan, Ting-Jing Shen, Thi Thuy Nguyen, Chiou-Feng Lin","doi":"10.1155/jotm/8376728","DOIUrl":"10.1155/jotm/8376728","url":null,"abstract":"<p><p>Dengue fever is highly prevalent in tropical and subtropical regions, where it is caused by dengue virus (DENV) and transmitted by arthropods. While DENV infection manifests with a spectrum of clinical symptoms, severe cases can lead to hemorrhagic fever and shock syndrome. Increasing evidence over the past decade has highlighted the neurological complications associated with DENV; however, the underlying mechanisms remain poorly understood. Despite this knowledge gap, various central nervous system (CNS)-targeted drugs have shown promise in mitigating DENV-induced neurological impairment. In this review, we provide an overview of the neurotropic features of DENV and summarize current evidence on the antiviral effects of selected nervous system-acting compounds. We also explore the potential mechanisms by which these agents may reduce DENV infection. Given the urgent need for effective dengue therapeutics, repurposing CNS-targeting drugs represents a promising strategy. Finally, we examine the potential and underlying mechanisms for employing neuropharmaceutical agents as one of the antiviral therapies for DENV infection.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"8376728"},"PeriodicalIF":2.5,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.1155/jotm/5405719
Elif Nur Yildirim-Ozturk
Background: Mosquito-borne diseases are a major cause of mortality and disease burden worldwide. This study aimed to assess the trends in total disability-adjusted life years (DALYs) due to five mosquito-borne diseases, as well as their association with poverty, gender inequality, underdevelopment, globalization, and climate change, both globally and for the period from 1990 to 2021.
Methods: This ecological time-series study with a longitudinal analytical framework used a total of 27 variables obtained from different sources. The dependent variable of the study was mosquito-borne DALYs. The trend of the numerical variables over time was analyzed using joinpoint regression. The relationships between the dependent variable and the independent variables were examined using univariate linear regression, LASSO regression, and ridge regression. p < 0.05 was considered statistically significant.
Results: During the study period, mosquito-borne DALYs decreased by 1.13 per 100,000 persons per year. The LASSO regression model explained 97.9% of the variability in mosquito-borne DALYs. Poverty headcount ratio at $6.85 a day, share of seats in parliament (female), global greenhouse gas emission, and Gender Inequality Index were found to be the most influential variables on mosquito-borne DALYs, respectively. When the optimum lambda, R2, MSE, and RMSE values were analyzed, the LASSO regression model was found to be more compatible than ridge regression for this data set.
Conclusion: The results demonstrate that mosquito-borne DALYs are primarily driven by poverty but are also influenced by gender inequality and climate change. These results highlight the urgent need for integrated and multifaceted public health strategies that go beyond traditional vector control methods.
{"title":"What Could Be Responsible for Some Mosquito-Borne Diseases? Is It Poverty, Gender Inequality, Underdevelopment, Globalization, or Climate Change? Which One(s)?","authors":"Elif Nur Yildirim-Ozturk","doi":"10.1155/jotm/5405719","DOIUrl":"10.1155/jotm/5405719","url":null,"abstract":"<p><strong>Background: </strong>Mosquito-borne diseases are a major cause of mortality and disease burden worldwide. This study aimed to assess the trends in total disability-adjusted life years (DALYs) due to five mosquito-borne diseases, as well as their association with poverty, gender inequality, underdevelopment, globalization, and climate change, both globally and for the period from 1990 to 2021.</p><p><strong>Methods: </strong>This ecological time-series study with a longitudinal analytical framework used a total of 27 variables obtained from different sources. The dependent variable of the study was mosquito-borne DALYs. The trend of the numerical variables over time was analyzed using joinpoint regression. The relationships between the dependent variable and the independent variables were examined using univariate linear regression, LASSO regression, and ridge regression. <i>p</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>During the study period, mosquito-borne DALYs decreased by 1.13 per 100,000 persons per year. The LASSO regression model explained 97.9% of the variability in mosquito-borne DALYs. Poverty headcount ratio at $6.85 a day, share of seats in parliament (female), global greenhouse gas emission, and Gender Inequality Index were found to be the most influential variables on mosquito-borne DALYs, respectively. When the optimum lambda, <i>R</i> <sup>2</sup>, MSE, and RMSE values were analyzed, the LASSO regression model was found to be more compatible than ridge regression for this data set.</p><p><strong>Conclusion: </strong>The results demonstrate that mosquito-borne DALYs are primarily driven by poverty but are also influenced by gender inequality and climate change. These results highlight the urgent need for integrated and multifaceted public health strategies that go beyond traditional vector control methods.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"5405719"},"PeriodicalIF":2.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145372819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-29eCollection Date: 2025-01-01DOI: 10.1155/jotm/7530351
Charles D Kato, Angella Musewa, Tequiero A Okumu, Margaret Mbuchi, Edwinah Atusingwize, Ivan Ankunda, Santiago C Tomas, Gloria Pol Ferrer, Benard Matovu, Emmanuel Muhumuza, Marta Planellas Bachs, Jesus Muro Figueres, James Robert Ochieng
To date, the reservoir host for visceral leishmaniasis, a neglected tropical disease caused by Leishmania donovani, is unknown, although studies pointing to dogs, domestic animals, and rodents are emerging. We aimed to investigate whether the dog (Canis familiaris, Linnaeus, 1758) is a potential reservoir for L. donovani in the Karamoja subregion of Uganda. Blood and lymph node aspirates were purposively collected from dogs (n = 139) in disease endemic villages of Amudat and Moroto districts in August 2023. An indirect enzyme-linked immunosorbent assay was used to detect anti-Leishmania IgG antibodies in serum. DNA extracted from lymph node aspirates was subjected to a polymerase chain reaction (PCR) targeting the rRNA internal transcribed spacer region of Leishmania species. The sera from 139 dogs did not demonstrate any evidence of circulating antibodies against Leishmania, as the optical density (OD) values were all below 0.25, lower than the threshold value of 0.45. Similarly, all the dog lymph node DNAs (n = 139) were negative for Leishmania parasites. Although our results found no evidence to support dogs as reservoirs for L. donovani, in this study, further research utilizing larger sample sizes is recommended to confirm this finding. Furthermore, the presence of L. donovani in sand flies and other suspected reservoirs, such as domestic animals and wild rodents, requires further investigation.
{"title":"Detection of <i>Leishmania donovani</i> Status in Dogs (<i>Canis familiaris,</i> Linnaeus, 1758) in the Karamoja Subregion of Uganda.","authors":"Charles D Kato, Angella Musewa, Tequiero A Okumu, Margaret Mbuchi, Edwinah Atusingwize, Ivan Ankunda, Santiago C Tomas, Gloria Pol Ferrer, Benard Matovu, Emmanuel Muhumuza, Marta Planellas Bachs, Jesus Muro Figueres, James Robert Ochieng","doi":"10.1155/jotm/7530351","DOIUrl":"10.1155/jotm/7530351","url":null,"abstract":"<p><p>To date, the reservoir host for visceral leishmaniasis, a neglected tropical disease caused by <i>Leishmania donovani</i>, is unknown, although studies pointing to dogs, domestic animals, and rodents are emerging. We aimed to investigate whether the dog (<i>Canis familiaris</i>, Linnaeus, 1758) is a potential reservoir for <i>L</i>. <i>donovan</i>i in the Karamoja subregion of Uganda. Blood and lymph node aspirates were purposively collected from dogs (<i>n</i> = 139) in disease endemic villages of Amudat and Moroto districts in August 2023. An indirect enzyme-linked immunosorbent assay was used to detect anti-<i>Leishmania</i> IgG antibodies in serum. DNA extracted from lymph node aspirates was subjected to a polymerase chain reaction (PCR) targeting the rRNA internal transcribed spacer region of <i>Leishmania</i> species. The sera from 139 dogs did not demonstrate any evidence of circulating antibodies against <i>Leishmania</i>, as the optical density (OD) values were all below 0.25, lower than the threshold value of 0.45. Similarly, all the dog lymph node DNAs (<i>n</i> = 139) were negative for <i>Leishmania</i> parasites. Although our results found no evidence to support dogs as reservoirs for <i>L</i>. <i>donovani</i>, in this study, further research utilizing larger sample sizes is recommended to confirm this finding. Furthermore, the presence of <i>L</i>. <i>donovani</i> in sand flies and other suspected reservoirs, such as domestic animals and wild rodents, requires further investigation.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"7530351"},"PeriodicalIF":2.5,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145244858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-22eCollection Date: 2025-01-01DOI: 10.1155/jotm/4939367
Babayemi O Olakunde, Daniel A Adeyinka, Olubunmi A Olakunde, Stanley C Eneh, Temitayo Ogundipe
Background: Nigeria has the highest burden of hepatitis B virus (HBV) infection in sub-Saharan Africa. However, the lack of a robust surveillance system and program data has limited the understanding of the burden and the distribution of HBV across different populations. This narrative review aimed to summarize available data on the epidemiology of HBV in Nigeria and identify research gaps in the existing literature. Methods: We searched PubMed, Scopus, and Google Scholar for relevant articles published between January 2000 and June 2025. Primary studies, reviews, and reports that contained data of interest, including prevalence, incidence, mode of transmission, mortality, and genotypes, were included in this review. Where available, we restricted our results to findings from representative surveys (conducted across the six geopolitical zones) or systematic reviews. Prevalence rates < 2%, 2%-7%, and ≥ 8% were described as low, intermediate, and high, respectively. Results: Studies on the prevalence of hepatitis B surface antigen (HBsAg) have reported intermediate to high rates in the general population (5.4%-13.6%), with evidence suggesting declining trend. The most recent estimates showed a prevalence of 5.4% in 2022, corresponding to approximately 14.4 million people living with HBV. Available data indicate sociodemographic disparities in HBV prevalence, with higher rates among men, adults (> 18 years), and rural dwellers. Reported prevalence rates among specific subpopulations include blood donors (13.2%-14.0%), pregnant women (5.5%-14.1%), prison inmates (4%-42.2%), people who inject drugs (7%-7.8%), healthcare workers (1.1%-25.7%), female sex workers (0%-17.1%), men who have sex with men (8.4%-11.7%), and transgender women (15.6%). The prevalence of hepatitis B e-antigen (HBeAg) in the general population ranged from 6.0% to 23.6%. The prevalence of occult HBV infection (OBI) ranged from 0.9% to 17.0%. Genotype E was consistently reported as the predominant HBV genotype. Most studies reported low, intermediate, and high prevalence rates for HBV-hepatitis C virus (HCV), HBV-hepatitis D virus (HDV), and HBV-HIV coinfections, respectively. In 2022, approximately 46,000 deaths were attributed to HBV, translating to a mortality rate of 21 per 100,000 population. Conclusions: A wide range of HBV prevalence rates has been observed across various population groups in Nigeria. Key research gaps in HBV epidemiology that must be addressed include modes of transmission, incidence rate, prevalence among key populations, prevalence of OBI in the general population, and spatial distribution of the burden.
{"title":"Epidemiology of Hepatitis B Virus Infection in Nigeria: A Narrative Review of Prevalence, Transmission, Genotypes, Coinfections, and Mortality.","authors":"Babayemi O Olakunde, Daniel A Adeyinka, Olubunmi A Olakunde, Stanley C Eneh, Temitayo Ogundipe","doi":"10.1155/jotm/4939367","DOIUrl":"10.1155/jotm/4939367","url":null,"abstract":"<p><p><b>Background:</b> Nigeria has the highest burden of hepatitis B virus (HBV) infection in sub-Saharan Africa. However, the lack of a robust surveillance system and program data has limited the understanding of the burden and the distribution of HBV across different populations. This narrative review aimed to summarize available data on the epidemiology of HBV in Nigeria and identify research gaps in the existing literature. <b>Methods:</b> We searched PubMed, Scopus, and Google Scholar for relevant articles published between January 2000 and June 2025. Primary studies, reviews, and reports that contained data of interest, including prevalence, incidence, mode of transmission, mortality, and genotypes, were included in this review. Where available, we restricted our results to findings from representative surveys (conducted across the six geopolitical zones) or systematic reviews. Prevalence rates < 2%, 2%-7%, and ≥ 8% were described as low, intermediate, and high, respectively. <b>Results:</b> Studies on the prevalence of hepatitis B surface antigen (HBsAg) have reported intermediate to high rates in the general population (5.4%-13.6%), with evidence suggesting declining trend. The most recent estimates showed a prevalence of 5.4% in 2022, corresponding to approximately 14.4 million people living with HBV. Available data indicate sociodemographic disparities in HBV prevalence, with higher rates among men, adults (> 18 years), and rural dwellers. Reported prevalence rates among specific subpopulations include blood donors (13.2%-14.0%), pregnant women (5.5%-14.1%), prison inmates (4%-42.2%), people who inject drugs (7%-7.8%), healthcare workers (1.1%-25.7%), female sex workers (0%-17.1%), men who have sex with men (8.4%-11.7%), and transgender women (15.6%). The prevalence of hepatitis B e-antigen (HBeAg) in the general population ranged from 6.0% to 23.6%. The prevalence of occult HBV infection (OBI) ranged from 0.9% to 17.0%. Genotype E was consistently reported as the predominant HBV genotype. Most studies reported low, intermediate, and high prevalence rates for HBV-hepatitis C virus (HCV), HBV-hepatitis D virus (HDV), and HBV-HIV coinfections, respectively. In 2022, approximately 46,000 deaths were attributed to HBV, translating to a mortality rate of 21 per 100,000 population. <b>Conclusions:</b> A wide range of HBV prevalence rates has been observed across various population groups in Nigeria. Key research gaps in HBV epidemiology that must be addressed include modes of transmission, incidence rate, prevalence among key populations, prevalence of OBI in the general population, and spatial distribution of the burden.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"4939367"},"PeriodicalIF":2.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15eCollection Date: 2025-01-01DOI: 10.1155/jotm/4460220
Getnet Atenafu, Netuhsew Atnaf
Due to the increasing resistance to synthetic insecticides and the proliferation of resistant strains of malaria vectors, plant-derived essential oils (EOs) are gaining prominence as an alternative for controlling Anopheles gambiae s.l. larvae. This study evaluated the larvicidal efficacy of EOs from Azadirachta indica and Schinus molle, both individually and in combination, against early 4th-instar Anopheles gambiae s.l. larvae under laboratory and semifield conditions. The EOs were extracted using ethanol in a Soxhlet apparatus. Twenty-five treatments were arranged in a completely randomized design for experimentation. Temephos (Abate) and distilled water served as positive and negative controls, respectively. Each treatment contained 20 larvae, which were acclimatized for 2 h prior to exposure to EOs. Treatment cups were covered with muslin cloth to prevent debris contamination. Larval mortality was assessed at 24, 48, and 72 h postexposure at concentrations of 25, 50, and 75 ppm. In the laboratory, A. indica oil exhibited the highest larvicidal activity among plant treatments, with 71.66% mortality at 75 ppm after 72 h, while S. molle and the combined treatment produced moderate effects. LC50 and LC90 values confirmed A. indica's superior potency, with significantly lower lethal concentrations across all exposure times (p < 0.05). In simulated field trials, A. indica oil also demonstrated time- and dose-dependent larvicidal activity, achieving 68.33% mortality at 75 ppm after 72 h. Synthetic larvicide Temephos (Abate) consistently caused 100% mortality within 24 h at all concentrations in both settings. These findings suggest that A. indica EO, particularly at higher concentrations and longer exposures, may serve as an effective botanical alternative for larval control in integrated vector management programs.
{"title":"Efficacy of Seed Oils From <i>Azadirachta indica</i> and <i>Schinus molle</i> and Their Combination Against <i>Anopheles gambiae</i> s.l.","authors":"Getnet Atenafu, Netuhsew Atnaf","doi":"10.1155/jotm/4460220","DOIUrl":"10.1155/jotm/4460220","url":null,"abstract":"<p><p>Due to the increasing resistance to synthetic insecticides and the proliferation of resistant strains of malaria vectors, plant-derived essential oils (EOs) are gaining prominence as an alternative for controlling <i>Anopheles gambiae s</i>.<i>l</i>. larvae. This study evaluated the larvicidal efficacy of EOs from <i>Azadirachta indica</i> and <i>Schinus molle</i>, both individually and in combination, against early 4<sup>th</sup>-instar <i>Anopheles gambiae s</i>.<i>l</i>. larvae under laboratory and semifield conditions. The EOs were extracted using ethanol in a Soxhlet apparatus. Twenty-five treatments were arranged in a completely randomized design for experimentation. Temephos (Abate) and distilled water served as positive and negative controls, respectively. Each treatment contained 20 larvae, which were acclimatized for 2 h prior to exposure to EOs. Treatment cups were covered with muslin cloth to prevent debris contamination. Larval mortality was assessed at 24, 48, and 72 h postexposure at concentrations of 25, 50, and 75 ppm. In the laboratory, <i>A. indica</i> oil exhibited the highest larvicidal activity among plant treatments, with 71.66% mortality at 75 ppm after 72 h, while <i>S. molle</i> and the combined treatment produced moderate effects. LC<sub>50</sub> and LC<sub>90</sub> values confirmed <i>A. indica</i>'s superior potency, with significantly lower lethal concentrations across all exposure times (<i>p</i> < 0.05). In simulated field trials, <i>A. indica</i> oil also demonstrated time- and dose-dependent larvicidal activity, achieving 68.33% mortality at 75 ppm after 72 h. Synthetic larvicide Temephos (Abate) consistently caused 100% mortality within 24 h at all concentrations in both settings. These findings suggest that <i>A. indica</i> EO, particularly at higher concentrations and longer exposures, may serve as an effective botanical alternative for larval control in integrated vector management programs.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"4460220"},"PeriodicalIF":2.5,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12453931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.1155/jotm/9827589
[This corrects the article DOI: 10.1155/jotm/5040196.].
[这更正了文章DOI: 10.1155/jotm/5040196.]。
{"title":"Corrigendum to \"Primary and Nested PCR Amplification of B1 Gene to Confirm Seropositivity of Toxoplasmosis Among Cancer Patients in Sri Lanka\".","authors":"","doi":"10.1155/jotm/9827589","DOIUrl":"https://doi.org/10.1155/jotm/9827589","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/jotm/5040196.].</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9827589"},"PeriodicalIF":2.5,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12446584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-10eCollection Date: 2025-01-01DOI: 10.1155/jotm/9760139
[This corrects the article DOI: 10.1155/jotm/1307578.].
[这更正了文章DOI: 10.1155/jotm/1307578.]。
{"title":"Corrigendum to \"Protocol for an Exploratory RCT of the Traumatic Stress Relief Intervention With Persons With Lived Experience of Leprosy in Addis Ababa, Ethiopia\".","authors":"","doi":"10.1155/jotm/9760139","DOIUrl":"https://doi.org/10.1155/jotm/9760139","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/jotm/1307578.].</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9760139"},"PeriodicalIF":2.5,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12443501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145086508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}